Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET, CT and MRI
نویسندگان
چکیده
منابع مشابه
Scar sarcoidosis on 18F-FDG PET/CT
18F-labeled fluoro-2-deoxyglucose positron emission tomography/ computed tomography (18F-FDG PET/CT) is an important imaging modality in the clinical workup of patients with chronic inflammatory disorders which present quite often with a fever of unknown origin. Sarcoidosis is a multisystem chronic inflammatory disorder with a wide clinical spectrum that can involve different organs. The diagno...
متن کاملStaging of Laryngeal and Hypopharyngeal Cancer: Computed Tomography versus Histopathology
Introduction: Computed tomography (CT) imaging is the choice of investigation for evaluation of extent of tumor under the mucosa, locally and regionally. This study was undertaken to assess the accuracy of preoperative CT imaging in the staging of carcinoma of the larynx and hypopharynx. Materials and Methods: In this retrospective study, all cases who were clinically (c) staged T3–T4 and w...
متن کاملFDG-PET/CT for cancer management.
FDG-PET/CT is increasingly being used for staging, restaging, and treatment monitoring for cancer patients. The introduction of a PET/CT system enables both morphological and metabolic imaging to be performed in a single session. Knowledge of the normal physiologic distribution of FDG and an understanding of the clinical indications and limitations of PET/CT enable accurate diagnosis and thus a...
متن کاملF-FDG PET/CT during neoadjuvant chemotherapy Running title: FDG-PET/CT for luminal breast cancer
Background: This prospective study aimed at evaluating the ability of 18 Ffluorodeoxyglucose Positron Emission Tomography/Computed Tomography ( 18 F-FDG PET/CT) to predict chemosensitivity in estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2-) breast cancer. Methods: 64 consecutive patients underwent 18 F-FDG PET/CT scans at baseline and after the second cou...
متن کاملPET/CT and MRI in Bladder Cancer.
Bladder Cancer (BCa) is the most common malignancy arising from the urinary tract. One of the mainstays of diagnosis, staging, and therapeutic decision-making for BCa is accurate and appropriate imaging. The ability to identify metastatic disease preoperatively is of utmost importance in determining treatment. Advances in standard cross sectional imaging techniques like Computed Tomography (CT)...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2017
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2017.02.005